Study on pharmacist PrEP training in Louisiana
Part of Infections clinical trials.
This trial looks at training pharmacists in Louisiana to prescribe PrEP, a daily pill that prevents HIV. It aims to see if training and monitoring can help more people get this prevention medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a community pharmacist in Louisiana.
- You provide PrEP (a pill to prevent HIV) to your customers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well pharmacists can provide PEP and PrEP (HIV prevention pills) using a special software called PEPPI. It aims to make it easier and faster for people to get these medicines.
This trial checks how well PrEP pills (TDF/FTC) prevent HIV in people who are at high risk and are HIV-negative. It may help you understand whether PrEP is a good prevention option for your situation.
This trial tests whether telehealth support can help people who inject drugs start and stay on PrEP (HIV prevention medicine). You will join several sessions and follow-up visits to see if this approach works better than standard care.
This study aims to help more trans women (and other women who were assigned male at birth) use or restart PrEP, a medication that helps prevent HIV. You may be eligible if you are HIV-uninfected, live in the New Orleans area, and can do regular follow-up visits.
This study tests whether pharmacies can safely provide HIV prevention medications (PrEP for prevention, PEP for emergency treatment) and HIV testing through phone or video visits. It aims to make these services easier to access without visiting a hospital or clinic.
This trial trains primary care providers at certain clinics to better offer PrEP, a daily pill that prevents HIV, to adolescents and young adults. If you are a provider at one of the listed clinics, you may be able to help improve how this prevention is delivered.
Hear when a new HIV Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.